7PARSONS SL, WATSON SA, BROWN PD, et al. Matrix metalloproteinases [J]. Br J Surg, 1997, 84 (2):160- 166.
8BAKER AH, ZALTSMAN AB, GEORGE SJ, et al. Divergent effects of tissue inhibitor of metalloproteinase - 1,- 2, or - 3 overexpression on rat vascular smooth muscle cell invasion, proliferation and death in vitro, TIMP - 3 promotes apoptosis [J]. J Clin Invest, 1998, 101 (6):1478- 1487.
9GREENE J, WANG M, LIU YE, et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase- 4 [J]. J Biol Chem, 1996, 271(48) : 30375 - 30380.
10STEINMANN - NIGGLI K, ZTSWILER R, KUNG M,et al. Inhibition of matrix metalloproteinases attenuates anti- Thy1. 1 nephritis [J ]. J Am Soc Nephrol,1998, 9 (3): 397-407.
二级参考文献25
1Schnaper HW. Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis. Pediatr Nephrol, 1995, 9: 104-111.
2Sakai H, Jinde K, Suzuki D, et al. Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy. Nephrol Dial Transplant, 1996, 11 Suppl 5 : 66-71.
3Miyazaki M, Koji T, Furusu A, et al. In situ hybridization studies of stromelysin and tissue inhibitor of metalloproteinase 1 in IgA nephropathy. Nephrology, 1995, 1: 119-127.
4Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol, 1982, 13: 314-322.
5Okada H, Suzuki H, Konishi K, et al. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Clin Nephrol, 1992, 37: 235-238.
7Toi M, Ishigaki S, Tominaga T. Metalloproteinases and tissue inhibitors of metalloproteinases. Breast Cancer Res Treat, 1998, 52: 113-124.
8Koide H, Nakamura T, Ebihara I, et al. Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy. Am J Kidney Dis, 1996, 28: 32-39.
9McMillan JI, Riordan JW, Couser WG, et al. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinse-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest, 1996, 97: 1094-1101.
10Suzuki D;Miyazaki M;Jinde K.In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type Ⅳ collagen in diabetic nephropathy[J],1997(1).
